| 1 | intention-to-treat | 4,113 |
| 2 | intent-to-treat | 1,659 |
| 3 | per-protocol | 1,037 |
| 4 | as-treated | 136 |
| 5 | completer | 136 |
| 6 | unweighted | 96 |
| 7 | bruce | 84 |
| 8 | last-observation-carried-forward | 77 |
| 9 | all-comers | 70 |
| 10 | complete-case | 34 |
| 11 | density-functional | 30 |
| 12 | according-to-protocol | 28 |
| 13 | liver-first | 27 |
| 14 | 1+1 | 25 |
| 15 | unstratified | 22 |
| 16 | emic | 19 |
| 17 | intention-to-screen | 18 |
| 18 | intention-to-treat-analysis | 13 |
| 19 | adf-hf | 12 |
| 20 | all-treated | 12 |
| 21 | homotopy | 12 |
| 22 | ovsynch-56 | 12 |
| 23 | fractographic | 11 |
| 24 | naughton | 9 |
| 25 | orthocad | 9 |
| 26 | value-of-information | 9 |
| 27 | accu-chek | 8 |
| 28 | fuzzy-trace | 8 |
| 29 | intension-to-treat | 8 |
| 30 | midvastus | 8 |
| 31 | smith-petersen | 8 |
| 32 | stoppa | 8 |
| 33 | aug-cc-pvdz | 7 |
| 34 | finite-field | 7 |
| 35 | intention-to-treatment | 7 |
| 36 | inter-network | 7 |
| 37 | markerlynx | 7 |
| 38 | microscan | 7 |
| 39 | ospedali | 7 |
| 40 | self-discrepancy | 7 |
| 41 | year-by-year | 7 |
| 42 | baseline-observation-carried-forward | 6 |
| 43 | decliner | 6 |
| 44 | early-access | 6 |
| 45 | eshap | 6 |
| 46 | excb | 6 |
| 47 | fire-and-forget | 6 |
| 48 | hplc-dad-esi/ms | 6 |
| 49 | isobolographic | 6 |
| 50 | meta-data | 6 |
| 51 | mitte | 6 |
| 52 | n-ethyl-n-nitrosourea | 6 |
| 53 | orthodontics-first | 6 |
| 54 | periscope | 6 |
| 55 | rucker | 6 |
| 56 | safety-first | 6 |
| 57 | to-treat | 6 |
| 58 | treatment-received | 6 |
| 59 | ardra | 5 |
| 60 | fixed-axis | 5 |
| 61 | flory-huggins | 5 |
| 62 | immunoseparation | 5 |
| 63 | landauer | 5 |
| 64 | pack-and-fill | 5 |
| 65 | per-vessel | 5 |
| 66 | upton | 5 |
| 67 | yang-monti | 5 |
| 68 | 5'-race | 4 |
| 69 | adolescent/adult | 4 |
| 70 | armyda-2 | 4 |
| 71 | available-case | 4 |
| 72 | avrami | 4 |
| 73 | bite-mark | 4 |
| 74 | cadm1/mal-methylation | 4 |
| 75 | costicartilage | 4 |
| 76 | distortion/interaction | 4 |
| 77 | ea-dse | 4 |
| 78 | fmsa | 4 |
| 79 | intend-to-treat | 4 |
| 80 | intention- | 4 |
| 81 | lcao | 4 |
| 82 | letrozole/antagonist | 4 |
| 83 | pancherz | 4 |
| 84 | post-facto | 4 |
| 85 | q-itt | 4 |
| 86 | sib-pair | 4 |
| 87 | tavr-nrca | 4 |
| 88 | velocity-based | 4 |
| 89 | 6-31g** | 3 |
| 90 | across-case | 3 |
| 91 | adse | 3 |
| 92 | age-period-cohort | 3 |
| 93 | all-patients | 3 |
| 94 | all-rifaximin | 3 |
| 95 | alpha9 | 3 |
| 96 | assess/advise/wait | 3 |
| 97 | atoms-in-molecules | 3 |
| 98 | auditive | 3 |
| 99 | c-qtc | 3 |
| 100 | evaluable-ppc | 3 |
| 101 | events-per-person-years | 3 |
| 102 | garífuna | 3 |
| 103 | integration-comparison | 3 |
| 104 | intention-to-diagnose | 3 |
| 105 | irt-dna-irt | 3 |
| 106 | itt-e | 3 |
| 107 | itt/pp | 3 |
| 108 | llc0405 | 3 |
| 109 | lmo | 3 |
| 110 | nuclear-family | 3 |
| 111 | omary | 3 |
| 112 | per-lobe | 3 |
| 113 | pm-mv | 3 |
| 114 | prevent-iv | 3 |
| 115 | ratio-comparison | 3 |
| 116 | rups | 3 |
| 117 | similia | 3 |
| 118 | structure-discriminant | 3 |
| 119 | targeted-core | 3 |
| 120 | tax/anthra | 3 |
| 121 | wave-intensity | 3 |
| 122 | york-mason | 3 |
| 123 | yunqi | 3 |
| 124 | 'interim | 2 |
| 125 | 6-311++g** | 2 |
| 126 | 6-311g* | 2 |
| 127 | 6-311g** | 2 |
| 128 | 80-kilovolt | 2 |
| 129 | adam-gibbs | 2 |
| 130 | adaptation-level | 2 |
| 131 | african/caribbean | 2 |
| 132 | afrikaner | 2 |
| 133 | all-study | 2 |
| 134 | alpha-theta | 2 |
| 135 | antenatal/perinatal | 2 |
| 136 | as-enrolled | 2 |
| 137 | balke | 2 |
| 138 | basecase | 2 |
| 139 | best-conformer-pair | 2 |
| 140 | bi-s-33 | 2 |
| 141 | bidomain | 2 |
| 142 | blame-the-victim | 2 |
| 143 | bohr | 2 |
| 144 | cc-pvtz | 2 |
| 145 | chi-square/fisher | 2 |
| 146 | compound-oriented | 2 |
| 147 | constant-infusion | 2 |
| 148 | construal-level | 2 |
| 149 | cost-effectiveness/cost-utility | 2 |
| 150 | cradle-to-grave | 2 |
| 151 | db-otm | 2 |
| 152 | derjaguin-landau-verwey-overbeek | 2 |
| 153 | dfns | 2 |
| 154 | dillman | 2 |
| 155 | dose-dilution | 2 |
| 156 | early-loading | 2 |
| 157 | ecobehavioral | 2 |
| 158 | efficacy-driven | 2 |
| 159 | efq | 2 |
| 160 | equation-of-state | 2 |
| 161 | excel-like | 2 |
| 162 | exocytic | 2 |
| 163 | explanatory-pragmatic | 2 |
| 164 | gastroplus | 2 |
| 165 | gouy-chapman | 2 |
| 166 | greentest | 2 |
| 167 | hodgkin-huxley | 2 |
| 168 | home-lite | 2 |
| 169 | in*compass | 2 |
| 170 | incidence-based | 2 |
| 171 | intent-to-intervene | 2 |
| 172 | intent-to-treat-population | 2 |
| 173 | intermittent-work | 2 |
| 174 | intersectional | 2 |
| 175 | ir64/n22 | 2 |
| 176 | isomorph | 2 |
| 177 | itt-a3 | 2 |
| 178 | itt-type | 2 |
| 179 | jain-khare | 2 |
| 180 | jingmai | 2 |
| 181 | last-visit-carried-forward | 2 |
| 182 | lc-pda-ms | 2 |
| 183 | localised-disease | 2 |
| 184 | lyon-schuss | 2 |
| 185 | m05-2x/def2-tzvpp | 2 |
| 186 | malondialdehide | 2 |
| 187 | nhl-bfm | 2 |
| 188 | observed-cases | 2 |
| 189 | osmo- | 2 |
| 190 | per-patient-based | 2 |
| 191 | per-segment-based | 2 |
| 192 | planewave | 2 |
| 193 | polyvagal | 2 |
| 194 | pre-published | 2 |
| 195 | programme/un | 2 |
| 196 | ribbon+margin | 2 |
| 197 | sensitization-homeostasis | 2 |
| 198 | sham-feeding | 2 |
| 199 | sma-first | 2 |
| 200 | sos//qm/mm | 2 |
| 201 | stabilogram-diffusion | 2 |
| 202 | sub-g0 | 2 |
| 203 | target-population | 2 |
| 204 | tend-and-befriend | 2 |
| 205 | three-ladder | 2 |
| 206 | turbidometric | 2 |
| 207 | ue-ts | 2 |
| 208 | vessel-collateral | 2 |
| 209 | 'exponential | 1 |
| 210 | 'implicit | 1 |
| 211 | 'recruitment | 1 |
| 212 | -57mmhg | 1 |
| 213 | 11.3-km | 1 |
| 214 | 13.2-20.2/100,000 | 1 |
| 215 | 17-92 | 1 |
| 216 | 4'-selenorna | 1 |
| 217 | 4dlv | 1 |
| 218 | 8,000-mg·d | 1 |
| 219 | 8-element | 1 |
| 220 | 8-ml | 1 |
| 221 | 8368-kj | 1 |
| 222 | accommodometer | 1 |
| 223 | acetonitrile/isopropanol | 1 |
| 224 | actor-network | 1 |
| 225 | actor/comedian | 1 |
| 226 | acttion | 1 |
| 227 | actual-intake | 1 |
| 228 | adaptive-choice | 1 |
| 229 | adeno-associate-virus | 1 |
| 230 | adequate-phosphorus | 1 |
| 231 | adherers-only | 1 |
| 232 | aflp-pcr | 1 |
| 233 | after-sun | 1 |
| 234 | age-structured | 1 |
| 235 | age-trend | 1 |
| 236 | agency-licensed | 1 |
| 237 | air-co | 1 |
| 238 | airsim | 1 |
| 239 | aldehyde/enol | 1 |
| 240 | all-control | 1 |
| 241 | all-exposed | 1 |
| 242 | all-island | 1 |
| 243 | all-japanese | 1 |
| 244 | all-patients-treated | 1 |
| 245 | alternative-mechanism-tnf-inhibitor | 1 |
| 246 | amethyst-c18-p | 1 |
| 247 | amitraz/fipronil/ | 1 |
| 248 | ancilliary | 1 |
| 249 | angiotensin-coverting-enzyme | 1 |
| 250 | animal-by-animal | 1 |
| 251 | ankle-brachial-index | 1 |
| 252 | annexinv/pi | 1 |
| 253 | ante-islamic | 1 |
| 254 | anti-dickkopf-1 | 1 |
| 255 | anti-gerbich | 1 |
| 256 | antibiotic-cycling | 1 |
| 257 | antiparsimony | 1 |
| 258 | antlion | 1 |
| 259 | anxiety-management | 1 |
| 260 | apnea/hypopneaindex | 1 |
| 261 | ar-alkyl-c- | 1 |
| 262 | ardian/medtronic | 1 |
| 263 | arylrhodium | 1 |
| 264 | as-naïve | 1 |
| 265 | as-randomized | 1 |
| 266 | as-used | 1 |
| 267 | asia-nested | 1 |
| 268 | assumption-free | 1 |
| 269 | attention-group | 1 |
| 270 | aug-cc-pvqz | 1 |
| 271 | aza-palladium | 1 |
| 272 | base-cohort | 1 |
| 273 | bet/bjh | 1 |
| 274 | biomarker-assessable | 1 |
| 275 | boek | 1 |
| 276 | burkhart/hogan | 1 |
| 277 | caregiver.the | 1 |
| 278 | channel-viscera | 1 |
| 279 | chemical-by-chemical | 1 |
| 280 | chinese-only | 1 |
| 281 | chip-qpcr | 1 |
| 282 | chipwide | 1 |
| 283 | chromotherapeutic | 1 |
| 284 | clinico-economic | 1 |
| 285 | colonialist | 1 |
| 286 | consort-ob | 1 |
| 287 | cross-genetic | 1 |
| 288 | d-aug-cc-pvdz | 1 |
| 289 | developmental/etiologic | 1 |
| 290 | dotter | 1 |
| 291 | double-edge | 1 |
| 292 | e2/p4-based | 1 |
| 293 | easi-breathe | 1 |
| 294 | ecclesiastic | 1 |
| 295 | ecmo-based | 1 |
| 296 | edxs | 1 |
| 297 | ee/levonorgestrel | 1 |
| 298 | ego-involving | 1 |
| 299 | eight-sector | 1 |
| 300 | electroantennographic | 1 |
| 301 | electrowetting-on-dielectric | 1 |
| 302 | enol-triflate | 1 |
| 303 | enzyme-supplemented | 1 |
| 304 | epiannular | 1 |
| 305 | epithelial-to-mesenchymal-transition | 1 |
| 306 | eq/ax | 1 |
| 307 | ericksen-leslie | 1 |
| 308 | error-reduced | 1 |
| 309 | esr1-to-centromere-6 | 1 |
| 310 | ethanwell/ethanzyme | 1 |
| 311 | ethopharmacological | 1 |
| 312 | evaluable-patients | 1 |
| 313 | evening-training-group | 1 |
| 314 | excess-acid | 1 |
| 315 | exclusive-or | 1 |
| 316 | exercise-injury | 1 |
| 317 | exo-1,3/1,4-β-glucanase | 1 |
| 318 | exo-ß-1,3-d-galactanase | 1 |
| 319 | exoscope | 1 |
| 320 | explanative | 1 |
| 321 | expression-study | 1 |
| 322 | extraction-transformation-loading | 1 |
| 323 | fda-affirmed | 1 |
| 324 | feelings-as-information | 1 |
| 325 | fetal-mortality | 1 |
| 326 | first-interim | 1 |
| 327 | foldback | 1 |
| 328 | four-corners | 1 |
| 329 | four-humor | 1 |
| 330 | full-analysis-set | 1 |
| 331 | g2-arrested | 1 |
| 332 | ge-neral | 1 |
| 333 | genotyping-by-sequencing | 1 |
| 334 | groups.preliminary | 1 |
| 335 | handshaking | 1 |
| 336 | hcl-pepsin-solution | 1 |
| 337 | hf/6-311++g** | 1 |
| 338 | high-needs | 1 |
| 339 | higher-latitude | 1 |
| 340 | hills-armitage | 1 |
| 341 | hla-1 | 1 |
| 342 | hole-particle | 1 |
| 343 | holo-endemic | 1 |
| 344 | homerus | 1 |
| 345 | homotpy | 1 |
| 346 | hpca-fe | 1 |
| 347 | humorism | 1 |
| 348 | hydroxymethyl-glutaryl-coa | 1 |
| 349 | i-graft | 1 |
| 350 | importance-performance | 1 |
| 351 | independent-port | 1 |
| 352 | independent-read | 1 |
| 353 | individual-herd | 1 |
| 354 | indo-pakistan | 1 |
| 355 | infant-mortality | 1 |
| 356 | infectious-immune | 1 |
| 357 | infliximab-mtx | 1 |
| 358 | inr≥2 | 1 |
| 359 | intended-to-treat | 1 |
| 360 | intent-to-continue | 1 |
| 361 | intent-to-diagnose | 1 |
| 362 | intent-to-immunize | 1 |
| 363 | intent-to-observe | 1 |
| 364 | intent-to-screen | 1 |
| 365 | intention-to-treat/safety | 1 |
| 366 | intermediate-like | 1 |
| 367 | interpersonal-psychological | 1 |
| 368 | interventionalist- | 1 |
| 369 | interview-group | 1 |
| 370 | intra-cerebroventricular | 1 |
| 371 | inverse-probability-of-treatment-weighted | 1 |
| 372 | ipass-like | 1 |
| 373 | ir64/giza178 | 1 |
| 374 | iso-n | 1 |
| 375 | israeli-muslim | 1 |
| 376 | jmil-only | 1 |
| 377 | kasha-exciton | 1 |
| 378 | koma | 1 |
| 379 | krummhörn | 1 |
| 380 | landau-type | 1 |
| 381 | lc100 | 1 |
| 382 | learning-disability | 1 |
| 383 | lifshitz-slyozov-wagner | 1 |
| 384 | linear-response | 1 |
| 385 | liver-transplant | 1 |
| 386 | log-rate-interval | 1 |
| 387 | lower-latitude | 1 |
| 388 | lps/d-galactosamine- | 1 |
| 389 | lq-parameter | 1 |
| 390 | m12l | 1 |
| 391 | magnetochemical | 1 |
| 392 | maintenance-eligible | 1 |
| 393 | maintenance-naïve | 1 |
| 394 | maintenance-nonprogressor | 1 |
| 395 | medicare-aged | 1 |
| 396 | metamodal | 1 |
| 397 | micro-zooplankton | 1 |
| 398 | microradiographic | 1 |
| 399 | microtopographic | 1 |
| 400 | mie-electrostatic | 1 |
| 401 | milyang23/giza178 | 1 |
| 402 | miscue | 1 |
| 403 | moral-rehabilitative | 1 |
| 404 | multivariated | 1 |
| 405 | n-h∙∙∙π | 1 |
| 406 | n-methyl-d-aspartate- | 1 |
| 407 | n2b/mismatch | 1 |
| 408 | nasogastric/orogastric | 1 |
| 409 | non-csc | 1 |
| 410 | oat-treated | 1 |
| 411 | obese/dysglycaemic | 1 |
| 412 | observed-group | 1 |
| 413 | occlusal-plane | 1 |
| 414 | odontectomy | 1 |
| 415 | onto-pathway | 1 |
| 416 | opiate-abuse | 1 |
| 417 | organic-mercury | 1 |
| 418 | organorhodium | 1 |
| 419 | osciliscope | 1 |
| 420 | outcome-contingent | 1 |
| 421 | over-selected | 1 |
| 422 | patient-perceptual | 1 |
| 423 | pedigree-based | 1 |
| 424 | per-attack | 1 |
| 425 | per-stent | 1 |
| 426 | pet-owning | 1 |
| 427 | pharma-material | 1 |
| 428 | pharmacolinetical | 1 |
| 429 | photoelasticity | 1 |
| 430 | phytase-phytate-pectin | 1 |
| 431 | pingelapese | 1 |
| 432 | plainland | 1 |
| 433 | plant.thematic | 1 |
| 434 | poison-evil | 1 |
| 435 | ppix-based | 1 |
| 436 | pre-matched | 1 |
| 437 | probability-classification | 1 |
| 438 | quadruple-ζ | 1 |
| 439 | rct-different | 1 |
| 440 | received-treatment | 1 |
| 441 | refutationist | 1 |
| 442 | rehm-weller | 1 |
| 443 | rotation-related | 1 |
| 444 | s-4 | 1 |
| 445 | safety/intent-to-treat | 1 |
| 446 | scarff | 1 |
| 447 | schumock | 1 |
| 448 | security-motivation | 1 |
| 449 | single-label | 1 |
| 450 | six-coincidence | 1 |
| 451 | smith-peterson | 1 |
| 452 | sociometer | 1 |
| 453 | soti/tropos | 1 |
| 454 | specical | 1 |
| 455 | stokes–einstein | 1 |
| 456 | structure-dimensional | 1 |
| 457 | sulzer-wieland | 1 |
| 458 | super-ageing | 1 |
| 459 | surgery-eligible | 1 |
| 460 | s⋯cg | 1 |
| 461 | t2g-orbital | 1 |
| 462 | tamatic | 1 |
| 463 | thermal-dynamic | 1 |
| 464 | thermal-gravimetric | 1 |
| 465 | threshold-utility | 1 |
| 466 | time-continuous | 1 |
| 467 | time-to-switch | 1 |
| 468 | time/motion | 1 |
| 469 | ultra-high-frequency | 1 |
| 470 | ultradisperser | 1 |
| 471 | ultramicroelectrode | 1 |
| 472 | ultraviolet-light | 1 |
| 473 | umbrian | 1 |
| 474 | univariated | 1 |
| 475 | usa-based | 1 |
| 476 | valid-for-safety | 1 |
| 477 | values-pragmatics | 1 |
| 478 | vandenberg | 1 |
| 479 | virchow-halsted | 1 |
| 480 | viscera-related | 1 |
| 481 | w-quad | 1 |
| 482 | wave-speed | 1 |
| 483 | whole-kidney | 1 |
| 484 | worker/workstation | 1 |
| 485 | world.s | 1 |
| 486 | world׳s | 1 |
| 487 | x-graft | 1 |
| 488 | x-scan | 1 |
| 489 | xlh-reference | 1 |
| 490 | ~nt | 1 |
| 491 | α-adjustment | 1 |
| 492 | α-starch | 1 |
| 1 | 'exponential | 1 |
| 2 | 'implicit | 1 |
| 3 | 'interim | 2 |
| 4 | 'recruitment | 1 |
| 5 | -57mmhg | 1 |
| 6 | 1+1 | 25 |
| 7 | 11.3-km | 1 |
| 8 | 13.2-20.2/100,000 | 1 |
| 9 | 17-92 | 1 |
| 10 | 4'-selenorna | 1 |
| 11 | 4dlv | 1 |
| 12 | 5'-race | 4 |
| 13 | 6-311++g** | 2 |
| 14 | 6-311g* | 2 |
| 15 | 6-311g** | 2 |
| 16 | 6-31g** | 3 |
| 17 | 8,000-mg·d | 1 |
| 18 | 8-element | 1 |
| 19 | 8-ml | 1 |
| 20 | 80-kilovolt | 2 |
| 21 | 8368-kj | 1 |
| 22 | accommodometer | 1 |
| 23 | according-to-protocol | 28 |
| 24 | accu-chek | 8 |
| 25 | acetonitrile/isopropanol | 1 |
| 26 | across-case | 3 |
| 27 | actor-network | 1 |
| 28 | actor/comedian | 1 |
| 29 | acttion | 1 |
| 30 | actual-intake | 1 |
| 31 | adam-gibbs | 2 |
| 32 | adaptation-level | 2 |
| 33 | adaptive-choice | 1 |
| 34 | adeno-associate-virus | 1 |
| 35 | adequate-phosphorus | 1 |
| 36 | adf-hf | 12 |
| 37 | adherers-only | 1 |
| 38 | adolescent/adult | 4 |
| 39 | adse | 3 |
| 40 | aflp-pcr | 1 |
| 41 | african/caribbean | 2 |
| 42 | afrikaner | 2 |
| 43 | after-sun | 1 |
| 44 | age-period-cohort | 3 |
| 45 | age-structured | 1 |
| 46 | age-trend | 1 |
| 47 | agency-licensed | 1 |
| 48 | air-co | 1 |
| 49 | airsim | 1 |
| 50 | aldehyde/enol | 1 |
| 51 | all-comers | 70 |
| 52 | all-control | 1 |
| 53 | all-exposed | 1 |
| 54 | all-island | 1 |
| 55 | all-japanese | 1 |
| 56 | all-patients | 3 |
| 57 | all-patients-treated | 1 |
| 58 | all-rifaximin | 3 |
| 59 | all-study | 2 |
| 60 | all-treated | 12 |
| 61 | alpha-theta | 2 |
| 62 | alpha9 | 3 |
| 63 | alternative-mechanism-tnf-inhibitor | 1 |
| 64 | amethyst-c18-p | 1 |
| 65 | amitraz/fipronil/ | 1 |
| 66 | ancilliary | 1 |
| 67 | angiotensin-coverting-enzyme | 1 |
| 68 | animal-by-animal | 1 |
| 69 | ankle-brachial-index | 1 |
| 70 | annexinv/pi | 1 |
| 71 | ante-islamic | 1 |
| 72 | antenatal/perinatal | 2 |
| 73 | anti-dickkopf-1 | 1 |
| 74 | anti-gerbich | 1 |
| 75 | antibiotic-cycling | 1 |
| 76 | antiparsimony | 1 |
| 77 | antlion | 1 |
| 78 | anxiety-management | 1 |
| 79 | apnea/hypopneaindex | 1 |
| 80 | ar-alkyl-c- | 1 |
| 81 | ardian/medtronic | 1 |
| 82 | ardra | 5 |
| 83 | armyda-2 | 4 |
| 84 | arylrhodium | 1 |
| 85 | as-enrolled | 2 |
| 86 | as-naïve | 1 |
| 87 | as-randomized | 1 |
| 88 | as-treated | 136 |
| 89 | as-used | 1 |
| 90 | asia-nested | 1 |
| 91 | assess/advise/wait | 3 |
| 92 | assumption-free | 1 |
| 93 | atoms-in-molecules | 3 |
| 94 | attention-group | 1 |
| 95 | auditive | 3 |
| 96 | aug-cc-pvdz | 7 |
| 97 | aug-cc-pvqz | 1 |
| 98 | available-case | 4 |
| 99 | avrami | 4 |
| 100 | aza-palladium | 1 |
| 101 | balke | 2 |
| 102 | base-cohort | 1 |
| 103 | basecase | 2 |
| 104 | baseline-observation-carried-forward | 6 |
| 105 | best-conformer-pair | 2 |
| 106 | bet/bjh | 1 |
| 107 | bi-s-33 | 2 |
| 108 | bidomain | 2 |
| 109 | biomarker-assessable | 1 |
| 110 | bite-mark | 4 |
| 111 | blame-the-victim | 2 |
| 112 | boek | 1 |
| 113 | bohr | 2 |
| 114 | bruce | 84 |
| 115 | burkhart/hogan | 1 |
| 116 | c-qtc | 3 |
| 117 | cadm1/mal-methylation | 4 |
| 118 | caregiver.the | 1 |
| 119 | cc-pvtz | 2 |
| 120 | channel-viscera | 1 |
| 121 | chemical-by-chemical | 1 |
| 122 | chi-square/fisher | 2 |
| 123 | chinese-only | 1 |
| 124 | chip-qpcr | 1 |
| 125 | chipwide | 1 |
| 126 | chromotherapeutic | 1 |
| 127 | clinico-economic | 1 |
| 128 | colonialist | 1 |
| 129 | complete-case | 34 |
| 130 | completer | 136 |
| 131 | compound-oriented | 2 |
| 132 | consort-ob | 1 |
| 133 | constant-infusion | 2 |
| 134 | construal-level | 2 |
| 135 | cost-effectiveness/cost-utility | 2 |
| 136 | costicartilage | 4 |
| 137 | cradle-to-grave | 2 |
| 138 | cross-genetic | 1 |
| 139 | d-aug-cc-pvdz | 1 |
| 140 | db-otm | 2 |
| 141 | decliner | 6 |
| 142 | density-functional | 30 |
| 143 | derjaguin-landau-verwey-overbeek | 2 |
| 144 | developmental/etiologic | 1 |
| 145 | dfns | 2 |
| 146 | dillman | 2 |
| 147 | distortion/interaction | 4 |
| 148 | dose-dilution | 2 |
| 149 | dotter | 1 |
| 150 | double-edge | 1 |
| 151 | e2/p4-based | 1 |
| 152 | ea-dse | 4 |
| 153 | early-access | 6 |
| 154 | early-loading | 2 |
| 155 | easi-breathe | 1 |
| 156 | ecclesiastic | 1 |
| 157 | ecmo-based | 1 |
| 158 | ecobehavioral | 2 |
| 159 | edxs | 1 |
| 160 | ee/levonorgestrel | 1 |
| 161 | efficacy-driven | 2 |
| 162 | efq | 2 |
| 163 | ego-involving | 1 |
| 164 | eight-sector | 1 |
| 165 | electroantennographic | 1 |
| 166 | electrowetting-on-dielectric | 1 |
| 167 | emic | 19 |
| 168 | enol-triflate | 1 |
| 169 | enzyme-supplemented | 1 |
| 170 | epiannular | 1 |
| 171 | epithelial-to-mesenchymal-transition | 1 |
| 172 | eq/ax | 1 |
| 173 | equation-of-state | 2 |
| 174 | ericksen-leslie | 1 |
| 175 | error-reduced | 1 |
| 176 | eshap | 6 |
| 177 | esr1-to-centromere-6 | 1 |
| 178 | ethanwell/ethanzyme | 1 |
| 179 | ethopharmacological | 1 |
| 180 | evaluable-patients | 1 |
| 181 | evaluable-ppc | 3 |
| 182 | evening-training-group | 1 |
| 183 | events-per-person-years | 3 |
| 184 | excb | 6 |
| 185 | excel-like | 2 |
| 186 | excess-acid | 1 |
| 187 | exclusive-or | 1 |
| 188 | exercise-injury | 1 |
| 189 | exo-1,3/1,4-β-glucanase | 1 |
| 190 | exo-ß-1,3-d-galactanase | 1 |
| 191 | exocytic | 2 |
| 192 | exoscope | 1 |
| 193 | explanative | 1 |
| 194 | explanatory-pragmatic | 2 |
| 195 | expression-study | 1 |
| 196 | extraction-transformation-loading | 1 |
| 197 | fda-affirmed | 1 |
| 198 | feelings-as-information | 1 |
| 199 | fetal-mortality | 1 |
| 200 | finite-field | 7 |
| 201 | fire-and-forget | 6 |
| 202 | first-interim | 1 |
| 203 | fixed-axis | 5 |
| 204 | flory-huggins | 5 |
| 205 | fmsa | 4 |
| 206 | foldback | 1 |
| 207 | four-corners | 1 |
| 208 | four-humor | 1 |
| 209 | fractographic | 11 |
| 210 | full-analysis-set | 1 |
| 211 | fuzzy-trace | 8 |
| 212 | g2-arrested | 1 |
| 213 | garífuna | 3 |
| 214 | gastroplus | 2 |
| 215 | ge-neral | 1 |
| 216 | genotyping-by-sequencing | 1 |
| 217 | gouy-chapman | 2 |
| 218 | greentest | 2 |
| 219 | groups.preliminary | 1 |
| 220 | handshaking | 1 |
| 221 | hcl-pepsin-solution | 1 |
| 222 | hf/6-311++g** | 1 |
| 223 | high-needs | 1 |
| 224 | higher-latitude | 1 |
| 225 | hills-armitage | 1 |
| 226 | hla-1 | 1 |
| 227 | hodgkin-huxley | 2 |
| 228 | hole-particle | 1 |
| 229 | holo-endemic | 1 |
| 230 | home-lite | 2 |
| 231 | homerus | 1 |
| 232 | homotopy | 12 |
| 233 | homotpy | 1 |
| 234 | hpca-fe | 1 |
| 235 | hplc-dad-esi/ms | 6 |
| 236 | humorism | 1 |
| 237 | hydroxymethyl-glutaryl-coa | 1 |
| 238 | i-graft | 1 |
| 239 | immunoseparation | 5 |
| 240 | importance-performance | 1 |
| 241 | in*compass | 2 |
| 242 | incidence-based | 2 |
| 243 | independent-port | 1 |
| 244 | independent-read | 1 |
| 245 | individual-herd | 1 |
| 246 | indo-pakistan | 1 |
| 247 | infant-mortality | 1 |
| 248 | infectious-immune | 1 |
| 249 | infliximab-mtx | 1 |
| 250 | inr≥2 | 1 |
| 251 | integration-comparison | 3 |
| 252 | intend-to-treat | 4 |
| 253 | intended-to-treat | 1 |
| 254 | intension-to-treat | 8 |
| 255 | intent-to-continue | 1 |
| 256 | intent-to-diagnose | 1 |
| 257 | intent-to-immunize | 1 |
| 258 | intent-to-intervene | 2 |
| 259 | intent-to-observe | 1 |
| 260 | intent-to-screen | 1 |
| 261 | intent-to-treat | 1,659 |
| 262 | intent-to-treat-population | 2 |
| 263 | intention- | 4 |
| 264 | intention-to-diagnose | 3 |
| 265 | intention-to-screen | 18 |
| 266 | intention-to-treat | 4,113 |
| 267 | intention-to-treat-analysis | 13 |
| 268 | intention-to-treat/safety | 1 |
| 269 | intention-to-treatment | 7 |
| 270 | inter-network | 7 |
| 271 | intermediate-like | 1 |
| 272 | intermittent-work | 2 |
| 273 | interpersonal-psychological | 1 |
| 274 | intersectional | 2 |
| 275 | interventionalist- | 1 |
| 276 | interview-group | 1 |
| 277 | intra-cerebroventricular | 1 |
| 278 | inverse-probability-of-treatment-weighted | 1 |
| 279 | ipass-like | 1 |
| 280 | ir64/giza178 | 1 |
| 281 | ir64/n22 | 2 |
| 282 | irt-dna-irt | 3 |
| 283 | iso-n | 1 |
| 284 | isobolographic | 6 |
| 285 | isomorph | 2 |
| 286 | israeli-muslim | 1 |
| 287 | itt-a3 | 2 |
| 288 | itt-e | 3 |
| 289 | itt-type | 2 |
| 290 | itt/pp | 3 |
| 291 | jain-khare | 2 |
| 292 | jingmai | 2 |
| 293 | jmil-only | 1 |
| 294 | kasha-exciton | 1 |
| 295 | koma | 1 |
| 296 | krummhörn | 1 |
| 297 | landau-type | 1 |
| 298 | landauer | 5 |
| 299 | last-observation-carried-forward | 77 |
| 300 | last-visit-carried-forward | 2 |
| 301 | lc-pda-ms | 2 |
| 302 | lc100 | 1 |
| 303 | lcao | 4 |
| 304 | learning-disability | 1 |
| 305 | letrozole/antagonist | 4 |
| 306 | lifshitz-slyozov-wagner | 1 |
| 307 | linear-response | 1 |
| 308 | liver-first | 27 |
| 309 | liver-transplant | 1 |
| 310 | llc0405 | 3 |
| 311 | lmo | 3 |
| 312 | localised-disease | 2 |
| 313 | log-rate-interval | 1 |
| 314 | lower-latitude | 1 |
| 315 | lps/d-galactosamine- | 1 |
| 316 | lq-parameter | 1 |
| 317 | lyon-schuss | 2 |
| 318 | m05-2x/def2-tzvpp | 2 |
| 319 | m12l | 1 |
| 320 | magnetochemical | 1 |
| 321 | maintenance-eligible | 1 |
| 322 | maintenance-naïve | 1 |
| 323 | maintenance-nonprogressor | 1 |
| 324 | malondialdehide | 2 |
| 325 | markerlynx | 7 |
| 326 | medicare-aged | 1 |
| 327 | meta-data | 6 |
| 328 | metamodal | 1 |
| 329 | micro-zooplankton | 1 |
| 330 | microradiographic | 1 |
| 331 | microscan | 7 |
| 332 | microtopographic | 1 |
| 333 | midvastus | 8 |
| 334 | mie-electrostatic | 1 |
| 335 | milyang23/giza178 | 1 |
| 336 | miscue | 1 |
| 337 | mitte | 6 |
| 338 | moral-rehabilitative | 1 |
| 339 | multivariated | 1 |
| 340 | n-ethyl-n-nitrosourea | 6 |
| 341 | n-h∙∙∙π | 1 |
| 342 | n-methyl-d-aspartate- | 1 |
| 343 | n2b/mismatch | 1 |
| 344 | nasogastric/orogastric | 1 |
| 345 | naughton | 9 |
| 346 | nhl-bfm | 2 |
| 347 | non-csc | 1 |
| 348 | nuclear-family | 3 |
| 349 | oat-treated | 1 |
| 350 | obese/dysglycaemic | 1 |
| 351 | observed-cases | 2 |
| 352 | observed-group | 1 |
| 353 | occlusal-plane | 1 |
| 354 | odontectomy | 1 |
| 355 | omary | 3 |
| 356 | onto-pathway | 1 |
| 357 | opiate-abuse | 1 |
| 358 | organic-mercury | 1 |
| 359 | organorhodium | 1 |
| 360 | orthocad | 9 |
| 361 | orthodontics-first | 6 |
| 362 | osciliscope | 1 |
| 363 | osmo- | 2 |
| 364 | ospedali | 7 |
| 365 | outcome-contingent | 1 |
| 366 | over-selected | 1 |
| 367 | ovsynch-56 | 12 |
| 368 | pack-and-fill | 5 |
| 369 | pancherz | 4 |
| 370 | patient-perceptual | 1 |
| 371 | pedigree-based | 1 |
| 372 | per-attack | 1 |
| 373 | per-lobe | 3 |
| 374 | per-patient-based | 2 |
| 375 | per-protocol | 1,037 |
| 376 | per-segment-based | 2 |
| 377 | per-stent | 1 |
| 378 | per-vessel | 5 |
| 379 | periscope | 6 |
| 380 | pet-owning | 1 |
| 381 | pharma-material | 1 |
| 382 | pharmacolinetical | 1 |
| 383 | photoelasticity | 1 |
| 384 | phytase-phytate-pectin | 1 |
| 385 | pingelapese | 1 |
| 386 | plainland | 1 |
| 387 | planewave | 2 |
| 388 | plant.thematic | 1 |
| 389 | pm-mv | 3 |
| 390 | poison-evil | 1 |
| 391 | polyvagal | 2 |
| 392 | post-facto | 4 |
| 393 | ppix-based | 1 |
| 394 | pre-matched | 1 |
| 395 | pre-published | 2 |
| 396 | prevent-iv | 3 |
| 397 | probability-classification | 1 |
| 398 | programme/un | 2 |
| 399 | q-itt | 4 |
| 400 | quadruple-ζ | 1 |
| 401 | ratio-comparison | 3 |
| 402 | rct-different | 1 |
| 403 | received-treatment | 1 |
| 404 | refutationist | 1 |
| 405 | rehm-weller | 1 |
| 406 | ribbon+margin | 2 |
| 407 | rotation-related | 1 |
| 408 | rucker | 6 |
| 409 | rups | 3 |
| 410 | s-4 | 1 |
| 411 | safety-first | 6 |
| 412 | safety/intent-to-treat | 1 |
| 413 | scarff | 1 |
| 414 | schumock | 1 |
| 415 | security-motivation | 1 |
| 416 | self-discrepancy | 7 |
| 417 | sensitization-homeostasis | 2 |
| 418 | sham-feeding | 2 |
| 419 | sib-pair | 4 |
| 420 | similia | 3 |
| 421 | single-label | 1 |
| 422 | six-coincidence | 1 |
| 423 | sma-first | 2 |
| 424 | smith-petersen | 8 |
| 425 | smith-peterson | 1 |
| 426 | sociometer | 1 |
| 427 | sos//qm/mm | 2 |
| 428 | soti/tropos | 1 |
| 429 | specical | 1 |
| 430 | stabilogram-diffusion | 2 |
| 431 | stokes–einstein | 1 |
| 432 | stoppa | 8 |
| 433 | structure-dimensional | 1 |
| 434 | structure-discriminant | 3 |
| 435 | sub-g0 | 2 |
| 436 | sulzer-wieland | 1 |
| 437 | super-ageing | 1 |
| 438 | surgery-eligible | 1 |
| 439 | s⋯cg | 1 |
| 440 | t2g-orbital | 1 |
| 441 | tamatic | 1 |
| 442 | target-population | 2 |
| 443 | targeted-core | 3 |
| 444 | tavr-nrca | 4 |
| 445 | tax/anthra | 3 |
| 446 | tend-and-befriend | 2 |
| 447 | thermal-dynamic | 1 |
| 448 | thermal-gravimetric | 1 |
| 449 | three-ladder | 2 |
| 450 | threshold-utility | 1 |
| 451 | time-continuous | 1 |
| 452 | time-to-switch | 1 |
| 453 | time/motion | 1 |
| 454 | to-treat | 6 |
| 455 | treatment-received | 6 |
| 456 | turbidometric | 2 |
| 457 | ue-ts | 2 |
| 458 | ultra-high-frequency | 1 |
| 459 | ultradisperser | 1 |
| 460 | ultramicroelectrode | 1 |
| 461 | ultraviolet-light | 1 |
| 462 | umbrian | 1 |
| 463 | univariated | 1 |
| 464 | unstratified | 22 |
| 465 | unweighted | 96 |
| 466 | upton | 5 |
| 467 | usa-based | 1 |
| 468 | valid-for-safety | 1 |
| 469 | value-of-information | 9 |
| 470 | values-pragmatics | 1 |
| 471 | vandenberg | 1 |
| 472 | velocity-based | 4 |
| 473 | vessel-collateral | 2 |
| 474 | virchow-halsted | 1 |
| 475 | viscera-related | 1 |
| 476 | w-quad | 1 |
| 477 | wave-intensity | 3 |
| 478 | wave-speed | 1 |
| 479 | whole-kidney | 1 |
| 480 | worker/workstation | 1 |
| 481 | world.s | 1 |
| 482 | world׳s | 1 |
| 483 | x-graft | 1 |
| 484 | x-scan | 1 |
| 485 | xlh-reference | 1 |
| 486 | yang-monti | 5 |
| 487 | year-by-year | 7 |
| 488 | york-mason | 3 |
| 489 | yunqi | 3 |
| 490 | ~nt | 1 |
| 491 | α-adjustment | 1 |
| 492 | α-starch | 1 |
| 1 | 6-311++g** | 2 |
| 2 | hf/6-311++g** | 1 |
| 3 | 6-311g** | 2 |
| 4 | 6-31g** | 3 |
| 5 | 6-311g* | 2 |
| 6 | ar-alkyl-c- | 1 |
| 7 | lps/d-galactosamine- | 1 |
| 8 | n-methyl-d-aspartate- | 1 |
| 9 | intention- | 4 |
| 10 | osmo- | 2 |
| 11 | interventionalist- | 1 |
| 12 | amitraz/fipronil/ | 1 |
| 13 | 13.2-20.2/100,000 | 1 |
| 14 | lc100 | 1 |
| 15 | sub-g0 | 2 |
| 16 | 1+1 | 25 |
| 17 | hla-1 | 1 |
| 18 | anti-dickkopf-1 | 1 |
| 19 | armyda-2 | 4 |
| 20 | ir64/n22 | 2 |
| 21 | 17-92 | 1 |
| 22 | inr≥2 | 1 |
| 23 | bi-s-33 | 2 |
| 24 | itt-a3 | 2 |
| 25 | s-4 | 1 |
| 26 | llc0405 | 3 |
| 27 | esr1-to-centromere-6 | 1 |
| 28 | ovsynch-56 | 12 |
| 29 | milyang23/giza178 | 1 |
| 30 | ir64/giza178 | 1 |
| 31 | alpha9 | 3 |
| 32 | tavr-nrca | 4 |
| 33 | n-ethyl-n-nitrosourea | 6 |
| 34 | similia | 3 |
| 35 | koma | 1 |
| 36 | 4'-selenorna | 1 |
| 37 | garífuna | 3 |
| 38 | hydroxymethyl-glutaryl-coa | 1 |
| 39 | stoppa | 8 |
| 40 | ardra | 5 |
| 41 | channel-viscera | 1 |
| 42 | tax/anthra | 3 |
| 43 | fmsa | 4 |
| 44 | meta-data | 6 |
| 45 | alpha-theta | 2 |
| 46 | excb | 6 |
| 47 | consort-ob | 1 |
| 48 | developmental/etiologic | 1 |
| 49 | microradiographic | 1 |
| 50 | isobolographic | 6 |
| 51 | electroantennographic | 1 |
| 52 | microtopographic | 1 |
| 53 | fractographic | 11 |
| 54 | ante-islamic | 1 |
| 55 | thermal-dynamic | 1 |
| 56 | emic | 19 |
| 57 | obese/dysglycaemic | 1 |
| 58 | holo-endemic | 1 |
| 59 | clinico-economic | 1 |
| 60 | ardian/medtronic | 1 |
| 61 | electrowetting-on-dielectric | 1 |
| 62 | thermal-gravimetric | 1 |
| 63 | turbidometric | 2 |
| 64 | nasogastric/orogastric | 1 |
| 65 | tamatic | 1 |
| 66 | plant.thematic | 1 |
| 67 | explanatory-pragmatic | 2 |
| 68 | mie-electrostatic | 1 |
| 69 | cross-genetic | 1 |
| 70 | ecclesiastic | 1 |
| 71 | chromotherapeutic | 1 |
| 72 | exocytic | 2 |
| 73 | evaluable-ppc | 3 |
| 74 | non-csc | 1 |
| 75 | c-qtc | 3 |
| 76 | orthocad | 9 |
| 77 | independent-read | 1 |
| 78 | w-quad | 1 |
| 79 | error-reduced | 1 |
| 80 | wave-speed | 1 |
| 81 | medicare-aged | 1 |
| 82 | pre-matched | 1 |
| 83 | pre-published | 2 |
| 84 | unstratified | 22 |
| 85 | as-enrolled | 2 |
| 86 | fda-affirmed | 1 |
| 87 | age-structured | 1 |
| 88 | e2/p4-based | 1 |
| 89 | usa-based | 1 |
| 90 | incidence-based | 2 |
| 91 | pedigree-based | 1 |
| 92 | ecmo-based | 1 |
| 93 | per-patient-based | 2 |
| 94 | per-segment-based | 2 |
| 95 | ppix-based | 1 |
| 96 | velocity-based | 4 |
| 97 | agency-licensed | 1 |
| 98 | all-exposed | 1 |
| 99 | as-used | 1 |
| 100 | all-treated | 12 |
| 101 | as-treated | 136 |
| 102 | all-patients-treated | 1 |
| 103 | oat-treated | 1 |
| 104 | univariated | 1 |
| 105 | multivariated | 1 |
| 106 | viscera-related | 1 |
| 107 | rotation-related | 1 |
| 108 | over-selected | 1 |
| 109 | inverse-probability-of-treatment-weighted | 1 |
| 110 | unweighted | 96 |
| 111 | compound-oriented | 2 |
| 112 | enzyme-supplemented | 1 |
| 113 | asia-nested | 1 |
| 114 | g2-arrested | 1 |
| 115 | virchow-halsted | 1 |
| 116 | treatment-received | 6 |
| 117 | as-randomized | 1 |
| 118 | excess-acid | 1 |
| 119 | finite-field | 7 |
| 120 | sulzer-wieland | 1 |
| 121 | plainland | 1 |
| 122 | all-island | 1 |
| 123 | tend-and-befriend | 2 |
| 124 | age-trend | 1 |
| 125 | baseline-observation-carried-forward | 6 |
| 126 | last-observation-carried-forward | 77 |
| 127 | last-visit-carried-forward | 2 |
| 128 | individual-herd | 1 |
| 129 | 8,000-mg·d | 1 |
| 130 | itt-e | 3 |
| 131 | per-lobe | 3 |
| 132 | 5'-race | 4 |
| 133 | fuzzy-trace | 8 |
| 134 | adaptive-choice | 1 |
| 135 | importance-performance | 1 |
| 136 | six-coincidence | 1 |
| 137 | xlh-reference | 1 |
| 138 | bruce | 84 |
| 139 | malondialdehide | 2 |
| 140 | chipwide | 1 |
| 141 | ultramicroelectrode | 1 |
| 142 | higher-latitude | 1 |
| 143 | lower-latitude | 1 |
| 144 | assumption-free | 1 |
| 145 | hpca-fe | 1 |
| 146 | costicartilage | 4 |
| 147 | hills-armitage | 1 |
| 148 | double-edge | 1 |
| 149 | caregiver.the | 1 |
| 150 | easi-breathe | 1 |
| 151 | ericksen-leslie | 1 |
| 152 | actual-intake | 1 |
| 153 | intermediate-like | 1 |
| 154 | excel-like | 2 |
| 155 | ipass-like | 1 |
| 156 | balke | 2 |
| 157 | biomarker-assessable | 1 |
| 158 | maintenance-eligible | 1 |
| 159 | surgery-eligible | 1 |
| 160 | hole-particle | 1 |
| 161 | ethanwell/ethanzyme | 1 |
| 162 | angiotensin-coverting-enzyme | 1 |
| 163 | occlusal-plane | 1 |
| 164 | intent-to-intervene | 2 |
| 165 | infectious-immune | 1 |
| 166 | osciliscope | 1 |
| 167 | periscope | 6 |
| 168 | exoscope | 1 |
| 169 | itt-type | 2 |
| 170 | landau-type | 1 |
| 171 | jain-khare | 2 |
| 172 | targeted-core | 3 |
| 173 | available-case | 4 |
| 174 | complete-case | 34 |
| 175 | across-case | 3 |
| 176 | basecase | 2 |
| 177 | localised-disease | 2 |
| 178 | exo-1,3/1,4-β-glucanase | 1 |
| 179 | exo-ß-1,3-d-galactanase | 1 |
| 180 | ea-dse | 4 |
| 181 | adse | 3 |
| 182 | all-japanese | 1 |
| 183 | pingelapese | 1 |
| 184 | linear-response | 1 |
| 185 | intention-to-diagnose | 3 |
| 186 | intent-to-diagnose | 1 |
| 187 | opiate-abuse | 1 |
| 188 | enol-triflate | 1 |
| 189 | equation-of-state | 2 |
| 190 | home-lite | 2 |
| 191 | mitte | 6 |
| 192 | miscue | 1 |
| 193 | intent-to-continue | 1 |
| 194 | cradle-to-grave | 2 |
| 195 | planewave | 2 |
| 196 | explanative | 1 |
| 197 | moral-rehabilitative | 1 |
| 198 | auditive | 3 |
| 199 | intent-to-observe | 1 |
| 200 | maintenance-naïve | 1 |
| 201 | as-naïve | 1 |
| 202 | intent-to-immunize | 1 |
| 203 | scarff | 1 |
| 204 | adf-hf | 12 |
| 205 | s⋯cg | 1 |
| 206 | -57mmhg | 1 |
| 207 | genotyping-by-sequencing | 1 |
| 208 | extraction-transformation-loading | 1 |
| 209 | early-loading | 2 |
| 210 | sham-feeding | 2 |
| 211 | super-ageing | 1 |
| 212 | handshaking | 1 |
| 213 | antibiotic-cycling | 1 |
| 214 | pet-owning | 1 |
| 215 | ego-involving | 1 |
| 216 | vandenberg | 1 |
| 217 | anti-gerbich | 1 |
| 218 | α-starch | 1 |
| 219 | n2b/mismatch | 1 |
| 220 | time-to-switch | 1 |
| 221 | bet/bjh | 1 |
| 222 | isomorph | 2 |
| 223 | jingmai | 2 |
| 224 | ospedali | 7 |
| 225 | avrami | 4 |
| 226 | annexinv/pi | 1 |
| 227 | yunqi | 3 |
| 228 | yang-monti | 5 |
| 229 | 8368-kj | 1 |
| 230 | foldback | 1 |
| 231 | per-attack | 1 |
| 232 | schumock | 1 |
| 233 | derjaguin-landau-verwey-overbeek | 2 |
| 234 | accu-chek | 8 |
| 235 | boek | 1 |
| 236 | bite-mark | 4 |
| 237 | intermittent-work | 2 |
| 238 | inter-network | 7 |
| 239 | actor-network | 1 |
| 240 | m12l | 1 |
| 241 | specical | 1 |
| 242 | ethopharmacological | 1 |
| 243 | interpersonal-psychological | 1 |
| 244 | chemical-by-chemical | 1 |
| 245 | magnetochemical | 1 |
| 246 | pharmacolinetical | 1 |
| 247 | metamodal | 1 |
| 248 | polyvagal | 2 |
| 249 | pharma-material | 1 |
| 250 | 'exponential | 1 |
| 251 | animal-by-animal | 1 |
| 252 | structure-dimensional | 1 |
| 253 | intersectional | 2 |
| 254 | density-functional | 30 |
| 255 | ge-neral | 1 |
| 256 | vessel-collateral | 2 |
| 257 | ecobehavioral | 2 |
| 258 | antenatal/perinatal | 2 |
| 259 | t2g-orbital | 1 |
| 260 | patient-perceptual | 1 |
| 261 | log-rate-interval | 1 |
| 262 | single-label | 1 |
| 263 | ee/levonorgestrel | 1 |
| 264 | per-vessel | 5 |
| 265 | construal-level | 2 |
| 266 | adaptation-level | 2 |
| 267 | poison-evil | 1 |
| 268 | pack-and-fill | 5 |
| 269 | 8-ml | 1 |
| 270 | according-to-protocol | 28 |
| 271 | per-protocol | 1,037 |
| 272 | acetonitrile/isopropanol | 1 |
| 273 | aldehyde/enol | 1 |
| 274 | all-control | 1 |
| 275 | nhl-bfm | 2 |
| 276 | israeli-muslim | 1 |
| 277 | 'interim | 2 |
| 278 | first-interim | 1 |
| 279 | airsim | 1 |
| 280 | blame-the-victim | 2 |
| 281 | 11.3-km | 1 |
| 282 | sos//qm/mm | 2 |
| 283 | humorism | 1 |
| 284 | db-otm | 2 |
| 285 | aza-palladium | 1 |
| 286 | arylrhodium | 1 |
| 287 | organorhodium | 1 |
| 288 | iso-n | 1 |
| 289 | x-scan | 1 |
| 290 | microscan | 7 |
| 291 | african/caribbean | 2 |
| 292 | burkhart/hogan | 1 |
| 293 | actor/comedian | 1 |
| 294 | umbrian | 1 |
| 295 | dillman | 2 |
| 296 | gouy-chapman | 2 |
| 297 | indo-pakistan | 1 |
| 298 | intention-to-screen | 18 |
| 299 | intent-to-screen | 1 |
| 300 | smith-petersen | 8 |
| 301 | efficacy-driven | 2 |
| 302 | bidomain | 2 |
| 303 | stokes–einstein | 1 |
| 304 | ribbon+margin | 2 |
| 305 | all-rifaximin | 3 |
| 306 | phytase-phytate-pectin | 1 |
| 307 | antlion | 1 |
| 308 | stabilogram-diffusion | 2 |
| 309 | constant-infusion | 2 |
| 310 | probability-classification | 1 |
| 311 | intent-to-treat-population | 2 |
| 312 | target-population | 2 |
| 313 | cadm1/mal-methylation | 4 |
| 314 | value-of-information | 9 |
| 315 | feelings-as-information | 1 |
| 316 | immunoseparation | 5 |
| 317 | worker/workstation | 1 |
| 318 | security-motivation | 1 |
| 319 | distortion/interaction | 4 |
| 320 | epithelial-to-mesenchymal-transition | 1 |
| 321 | time/motion | 1 |
| 322 | acttion | 1 |
| 323 | dose-dilution | 2 |
| 324 | hcl-pepsin-solution | 1 |
| 325 | york-mason | 3 |
| 326 | integration-comparison | 3 |
| 327 | ratio-comparison | 3 |
| 328 | smith-peterson | 1 |
| 329 | naughton | 9 |
| 330 | kasha-exciton | 1 |
| 331 | micro-zooplankton | 1 |
| 332 | upton | 5 |
| 333 | krummhörn | 1 |
| 334 | programme/un | 2 |
| 335 | after-sun | 1 |
| 336 | lcao | 4 |
| 337 | air-co | 1 |
| 338 | lmo | 3 |
| 339 | post-facto | 4 |
| 340 | amethyst-c18-p | 1 |
| 341 | eshap | 6 |
| 342 | itt/pp | 3 |
| 343 | m05-2x/def2-tzvpp | 2 |
| 344 | observed-group | 1 |
| 345 | evening-training-group | 1 |
| 346 | attention-group | 1 |
| 347 | interview-group | 1 |
| 348 | efq | 2 |
| 349 | year-by-year | 7 |
| 350 | intra-cerebroventricular | 1 |
| 351 | epiannular | 1 |
| 352 | aflp-pcr | 1 |
| 353 | chip-qpcr | 1 |
| 354 | three-ladder | 2 |
| 355 | chi-square/fisher | 2 |
| 356 | rucker | 6 |
| 357 | rehm-weller | 1 |
| 358 | afrikaner | 2 |
| 359 | lifshitz-slyozov-wagner | 1 |
| 360 | decliner | 6 |
| 361 | ultradisperser | 1 |
| 362 | completer | 136 |
| 363 | lq-parameter | 1 |
| 364 | accommodometer | 1 |
| 365 | sociometer | 1 |
| 366 | dotter | 1 |
| 367 | landauer | 5 |
| 368 | bohr | 2 |
| 369 | sib-pair | 4 |
| 370 | best-conformer-pair | 2 |
| 371 | exclusive-or | 1 |
| 372 | four-humor | 1 |
| 373 | maintenance-nonprogressor | 1 |
| 374 | eight-sector | 1 |
| 375 | alternative-mechanism-tnf-inhibitor | 1 |
| 376 | world.s | 1 |
| 377 | adam-gibbs | 2 |
| 378 | values-pragmatics | 1 |
| 379 | high-needs | 1 |
| 380 | atoms-in-molecules | 3 |
| 381 | observed-cases | 2 |
| 382 | sensitization-homeostasis | 2 |
| 383 | intention-to-treat-analysis | 13 |
| 384 | fixed-axis | 5 |
| 385 | lc-pda-ms | 2 |
| 386 | hplc-dad-esi/ms | 6 |
| 387 | dfns | 2 |
| 388 | flory-huggins | 5 |
| 389 | soti/tropos | 1 |
| 390 | rups | 3 |
| 391 | events-per-person-years | 3 |
| 392 | all-comers | 70 |
| 393 | four-corners | 1 |
| 394 | in*compass | 2 |
| 395 | early-access | 6 |
| 396 | lyon-schuss | 2 |
| 397 | ue-ts | 2 |
| 398 | evaluable-patients | 1 |
| 399 | all-patients | 3 |
| 400 | gastroplus | 2 |
| 401 | time-continuous | 1 |
| 402 | homerus | 1 |
| 403 | adeno-associate-virus | 1 |
| 404 | adequate-phosphorus | 1 |
| 405 | midvastus | 8 |
| 406 | edxs | 1 |
| 407 | world׳s | 1 |
| 408 | to-treat | 6 |
| 409 | intended-to-treat | 1 |
| 410 | intend-to-treat | 4 |
| 411 | intension-to-treat | 8 |
| 412 | intention-to-treat | 4,113 |
| 413 | intent-to-treat | 1,659 |
| 414 | safety/intent-to-treat | 1 |
| 415 | fire-and-forget | 6 |
| 416 | full-analysis-set | 1 |
| 417 | i-graft | 1 |
| 418 | x-graft | 1 |
| 419 | ultraviolet-light | 1 |
| 420 | assess/advise/wait | 3 |
| 421 | 'implicit | 1 |
| 422 | 80-kilovolt | 2 |
| 423 | adolescent/adult | 4 |
| 424 | liver-transplant | 1 |
| 425 | structure-discriminant | 3 |
| 426 | outcome-contingent | 1 |
| 427 | anxiety-management | 1 |
| 428 | 8-element | 1 |
| 429 | received-treatment | 1 |
| 430 | intention-to-treatment | 7 |
| 431 | 'recruitment | 1 |
| 432 | α-adjustment | 1 |
| 433 | rct-different | 1 |
| 434 | per-stent | 1 |
| 435 | ~nt | 1 |
| 436 | irt-dna-irt | 3 |
| 437 | age-period-cohort | 3 |
| 438 | base-cohort | 1 |
| 439 | independent-port | 1 |
| 440 | greentest | 2 |
| 441 | colonialist | 1 |
| 442 | letrozole/antagonist | 4 |
| 443 | refutationist | 1 |
| 444 | sma-first | 2 |
| 445 | liver-first | 27 |
| 446 | orthodontics-first | 6 |
| 447 | safety-first | 6 |
| 448 | q-itt | 4 |
| 449 | prevent-iv | 3 |
| 450 | 4dlv | 1 |
| 451 | pm-mv | 3 |
| 452 | eq/ax | 1 |
| 453 | ankle-brachial-index | 1 |
| 454 | apnea/hypopneaindex | 1 |
| 455 | markerlynx | 7 |
| 456 | infliximab-mtx | 1 |
| 457 | onto-pathway | 1 |
| 458 | self-discrepancy | 7 |
| 459 | ultra-high-frequency | 1 |
| 460 | all-study | 2 |
| 461 | expression-study | 1 |
| 462 | hodgkin-huxley | 2 |
| 463 | whole-kidney | 1 |
| 464 | nuclear-family | 3 |
| 465 | chinese-only | 1 |
| 466 | jmil-only | 1 |
| 467 | adherers-only | 1 |
| 468 | odontectomy | 1 |
| 469 | antiparsimony | 1 |
| 470 | homotopy | 12 |
| 471 | homotpy | 1 |
| 472 | ancilliary | 1 |
| 473 | omary | 3 |
| 474 | groups.preliminary | 1 |
| 475 | organic-mercury | 1 |
| 476 | exercise-injury | 1 |
| 477 | valid-for-safety | 1 |
| 478 | intention-to-treat/safety | 1 |
| 479 | photoelasticity | 1 |
| 480 | fetal-mortality | 1 |
| 481 | infant-mortality | 1 |
| 482 | learning-disability | 1 |
| 483 | threshold-utility | 1 |
| 484 | cost-effectiveness/cost-utility | 2 |
| 485 | wave-intensity | 3 |
| 486 | aug-cc-pvdz | 7 |
| 487 | d-aug-cc-pvdz | 1 |
| 488 | aug-cc-pvqz | 1 |
| 489 | pancherz | 4 |
| 490 | cc-pvtz | 2 |
| 491 | n-h∙∙∙π | 1 |
| 492 | quadruple-ζ | 1 |